Clinical Trials Directory

Trials / Unknown

UnknownNCT00776568

Treatment of Refractory Angina Pectoris by Shock Wave Therapy

Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Refractory Angina Pectoris

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Universal Research Group · Network
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine that extracorporeal shock wave therapy (ESWT) is safe and effective for the treatment of refractory angina pectoris.

Detailed description

Patients with advanced CAD frequently have limited symptoms with recurrent angina, angina at low work thresholds, breathlessness, and other debilitating conditions. These patients have often been through several "re-do" coronary bypass procedures and multiple percutaneous coronary interventions. Surgical and interventional options for these patients typically have been exhausted or will result in only partial revascularization. Therefore, therapy remains limited to the use of multiple anti-anginal medications, reduced activity, exertion, and stress level, and significant alteration and limitation of lifestyle. The goal of this emerging approach is to therapeutically induce the growth and development of new vasculature in zones of severe ischemia in the myocardium, with the hope that new capillaries and arterioles generated will connect to remnant existing vasculature. These neovessels are viewed to act as collaterals, perfusing ischemic territories unapproachable by macro procedures such as PCI and/or CABG.

Conditions

Interventions

TypeNameDescription
PROCEDUREExtra-corporeal shockwaveLow intensity shock waves are applied as 300 shocks per visit for 09 visits. The treatment visit is carried at week 1, 5 and 9.
DRUGAnti-hypertensive drugsACE inhibitors, Ca channel blockers, Beta blockers, Diuretics, Cholesterol lowering agents and/or other drugs used alone or in combination, as prescribed.

Timeline

Start date
2008-02-01
Primary completion
2009-08-01
First posted
2008-10-21
Last updated
2008-10-21

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT00776568. Inclusion in this directory is not an endorsement.